• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Radiopharmaceuticals for Sentinel Lymph Node Detection: Status and Trends

English STI/PUB/1674 978-92-0-109714-9
162 43 39.00 2015

Download PDF (2.43 MB)

Description

This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspects of this diagnostic methodology, including the production of nanocolloidal particles, their biological mechanism of action and relevant clinical applications. It also illustrates the recent developments in the field fuelled by the introduction of molecular imaging agents for SLND and of multimodality optical and radioactive agents. Included in the results presented in this book, are those on the novel generation of SLND radiopharmaceuticals obtained through an IAEA coordinated research project.

More Information on reusing IAEA copyright material.

Keywords

IAEA Radioisotopes and Radiopharmaceuticals, Radioactive Tracers, Lymph Nodes, Cancer, Diagnostic Radiopharmaceuticals, Sentinel Lymph Node Detection, SLND, Biopsy, SLNB, Mammary Glands, Melanomas, Lymphatic System

How to order

Ordering Locally

Please use the following links for an up-to-date list of IAEA distributors:

Distributors of IAEA Publications


Orders and requests for information may also be addressed to:

Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria

Tel.: +43 1 2600 22529, +43 1 2600 22530
Fax: +43 1 2600 29302
Email: sales.publications@iaea.org


Download order form

Resources

  1. Employment
  2. Women
  3. Press

Stay in touch

Newsletter